U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460817) titled 'A Brief Intervention for PTSD - BWRT' on May 24, 2021. Brief Summary: The purpose of this... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460908) titled 'Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome' on Mar... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460635) titled 'Pilot Evaluation of Digital Peer-Support Intervention for College Students' on March 03. ... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461675) titled 'Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma P... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461051) titled 'Effects of Foot Bath Therapy on Premenstrual Syndrome Symptoms, Quality of Life, and Pain'... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07462728) titled 'Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiothe... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461831) titled 'CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma' o... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460245) titled 'Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urotheli... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460895) titled 'Effectiveness of Photobiomodulation for Myofascial Pain in Temporomandibular Disorders' on... Read More
U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461259) titled 'Safety and Feasibility of TWIICE Rise - Phase 2' on April 22, 2024. Brief Summary: The ai... Read More